SCHEMBL13620234

SCHEMBL13620234

O=c1[nH]c2cnc(NC[C@H]3CCNC3)nc2n1Cc1cc(Cl)ccc1CC(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.39
BRD4 O60885 1/20 0.35
ATAD2 Q6PL18 1/20 0.35
HSP90AA1 P07900 1/20 0.34
HSP90B1 P14625 1/20 0.34
TRAP1 Q12931 1/20 0.34
MAOB P27338 2/20 0.34
HTR6 P50406 2/20 0.34
DDR1 Q08345 4/20 0.34
CHEK1 O14757 3/20 0.34
FLT3 P36888 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
PRKCQ Q04759 1/20 0.33
USP1 O94782 2/20 0.33
CNR2 P34972 1/20 0.33
CDK4 P11802 1/20 0.33
CCR4 P51679 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13620502 0.95 CHEK1 (0.37) KDM1ABRD4ATAD2HSP90AA1HSP90B1
SCHEMBL13620503 0.95 CHEK1 (0.37) KDM1ABRD4ATAD2HSP90AA1HSP90B1
SCHEMBL13620280 0.94 HSP90AA1 (0.36) HSP90AA1HSP90B1TRAP1DDR1USP1
SCHEMBL13608322 0.90 HSP90AA1 (0.44) KDM1ABRD4ATAD2HSP90AA1HSP90B1
SCHEMBL13608142 0.89 KDM1A (0.44) KDM1ABRD4ATAD2HSP90AA1HSP90B1
SCHEMBL13608341 0.89 KDM1A (0.44) KDM1ABRD4ATAD2MAOBHTR6
SCHEMBL13608260 0.87 BRD4 (0.42) KDM1ABRD4ATAD2HSP90AA1HSP90B1
SCHEMBL13608264 0.85 KDM1A (0.39) KDM1ABRD4ATAD2DDR1JAK2
SCHEMBL13608434 0.84 KDM1A (0.45) KDM1ABRD4ATAD2MAOBHTR6
SCHEMBL12371714 0.84 KDM1A (0.43) KDM1ABRD4ATAD2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281075-A1 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PHARMACOPEIA, INC. (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281075-A1 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS PRKCE, PRKCZ, PRKCQ KDM1A 1070/4885BRD4 1920/4885ATAD2 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.